T. Rowe Price Associates’s Bionano Genomics BNGO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,173
| Closed | -$20K | – | 3042 |
|
|
2024
Q4 | $20K | Hold |
1,173
| – | – | ﹤0.01% | 2984 |
|
|
2024
Q3 | $32K | Hold |
1,173
| – | – | ﹤0.01% | 2967 |
|
|
2024
Q2 | $48K | Hold |
1,173
| – | – | ﹤0.01% | 2860 |
|
|
2024
Q1 | $79K | Buy |
1,173
+648
| +123% | +$43.6K | ﹤0.01% | 2816 |
|
|
2023
Q4 | $60K | Buy |
525
+342
| +187% | +$39.1K | ﹤0.01% | 2776 |
|
|
2023
Q3 | $34K | Buy |
183
+88
| +93% | +$16.4K | ﹤0.01% | 2814 |
|
|
2023
Q2 | $35K | Sell |
95
-92
| -49% | -$33.9K | ﹤0.01% | 2834 |
|
|
2023
Q1 | $125K | Buy |
187
+7
| +4% | +$4.68K | ﹤0.01% | 2638 |
|
|
2022
Q4 | $158K | Buy |
180
+10
| +6% | +$8.78K | ﹤0.01% | 2605 |
|
|
2022
Q3 | $187K | Buy |
170
+29
| +21% | +$31.9K | ﹤0.01% | 2565 |
|
|
2022
Q2 | $116K | Buy |
141
+3
| +2% | +$2.47K | ﹤0.01% | 2722 |
|
|
2022
Q1 | $214K | Buy |
138
+10
| +8% | +$15.5K | ﹤0.01% | 2681 |
|
|
2021
Q4 | $229K | Sell |
128
-43
| -25% | -$76.9K | ﹤0.01% | 2704 |
|
|
2021
Q3 | $563K | Buy |
171
+45
| +36% | +$148K | ﹤0.01% | 2322 |
|
|
2021
Q2 | $553K | Buy |
126
+41
| +48% | +$180K | ﹤0.01% | 2339 |
|
|
2021
Q1 | $414K | Buy |
+85
| New | +$414K | ﹤0.01% | 2448 |
|